Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Aug;39(8):4832-9.
doi: 10.1118/1.4736516.

In vivo assessment of optimal b-value range for perfusion-insensitive apparent diffusion coefficient imaging

Affiliations

In vivo assessment of optimal b-value range for perfusion-insensitive apparent diffusion coefficient imaging

Moti Freiman et al. Med Phys. 2012 Aug.

Abstract

Purpose: To assess the optimal b-values range for perfusion-insensitive apparent diffusion coefficient (ADC) imaging of abdominal organs using short-duration DW-MRI acquisitions with currently available ADC estimation methods.

Methods: DW-MRI data of 15 subjects were acquired with eight b-values in the range of 5-800 s∕mm(2). The reference-standard, a perfusion insensitive, ADC value (ADC(IVIM)), was computed using an intravoxel incoherent motion (IVIM) model with all acquired diffusion-weighted images. Simulated DW-MRI data was generated using an IVIM model with b-values in the range of 0-1200 s∕mm(2). Monoexponential ADC estimates were calculated using: (1) Two-point estimator (ADC(2)); (2) least squares three-point (ADC(3)) estimator and; (3) Rician noise model estimator (ADC(R)). The authors found the optimal b-values for perfusion-insensitive ADC calculations by minimizing the relative root mean square error (RRMS) between the ADC(IVIM) and the monoexponential ADC values for each estimation method and organ.

Results: Low b-value = 300 s∕mm(2) and high b-value = 1200 s∕mm(2) minimized the RRMS between the estimated ADC and the reference-standard ADC(IVIM) to less than 5% using the ADC(3) estimator. By considering only the in vivo DW-MRI data, the combination of low b-value = 270 s∕mm(2) and high b-value of 800 s∕mm(2) minimized the RRMS between the estimated ADC and the reference-standard ADC(IVIM) to <7% using the ADC(3) estimator. For all estimators, the RRMS between the estimated ADC and the reference standard ADC correlated strongly with the perfusion-fraction parameter of the IVIM model (r = [0.78-0.83], p ≤ 0.003).

Conclusions: The perfusion compartment in DW-MRI signal decay correlates strongly with the RRMS in ADC estimates from short-duration DW-MRI. The impact of the perfusion compartment on ADC estimations depends, however, on the choice of b-values and estimation method utilized. Likewise, perfusion-related errors can be reduced to <7% by carefully selecting the b-values used for ADC calculations and method of estimation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Representative ADC maps (first row) and liver (encircled) signal-decay plots (second row) organized according to the minimal b-value used to calculate the ADC. The ADC maps were calculated using the ADC2 estimator with fixed bmax = 800 s/mm2 and varying bmin. The discrepancy between the ADC2 and the slow-diffusion component of the IVIM model (ADCIVIM) decreases as the bmin increases.
Figure 2
Figure 2
The relative root mean squared error surface between the ADC estimates from the simulated DW-MRI data and the reference standard ADCIVIM as a function of the bmin and bmax. The surfaces are organized according to the organ (rows) and the ADC estimator (columns).
Figure 3
Figure 3
The relative root mean squared error surface between the ADC estimates from the in vivo DW-MRI data and the reference standard ADCIVIM as a function of the bmin and bmax. The surfaces are organized according to the organ (rows) and the ADC estimator (columns).

References

    1. Stejskal E. O. and Tanner J. E., “Spin diffusion measurements: spin-echo in the presence of a time dependent field gradient,” J. Chem. Phys. 42, 288–292 (1965). 10.1063/1.1695690 - DOI
    1. Gumustas S., Inan N., Sarisoy H. T., Anik Y., Arslan A., Ciftci E., Akansel G., and Demirci A., “Malignant versus benign mediastinal lesions: quantitative assessment with diffusion weighted MR imaging,” Eur Radiol. 21, 2255–2260 (2011). - PubMed
    1. Vargas H. A., Akin O., Franiel T., Mazaheri Y., Zheng J., Moskowitz C., Udo K., Eastham J., and Hricak H., “Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: Tumor detection and assessment of aggressiveness,” Radiology 259, 775–784 (2011). 10.1148/radiol.11102066 - DOI - PMC - PubMed
    1. Dudeck O., Zeile M., Pink D., Pech M., Tunn P.-U., Reichardt P., Ludwig W.-D., and Hamm B., “Diffusion-weighted magnetic resonance imaging allows monitoring of anticancer treatment effects in patients with soft-tissue sarcomas,” J. Magn. Reson. Imaging 27, 1109–1113 (2008). 10.1002/jmri.21358 - DOI - PubMed
    1. Eccles C. L., Haider E. A., Haider M. A., Fung S., Lockwood G., and Dawson L. A., “Change in diffusion weighted MRI during liver cancer radiotherapy: Preliminary observations,” Acta Oncol. 48, 1034–1043 (2009). 10.1080/02841860903099972 - DOI - PubMed

Publication types